Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics

International Journal of Antimicrobial Agents

Volumn 29, Issue 2, 2007, Pages 207-211

  Pereyre, S ^a   Metifiot M ^a   Cazanave, C ^a   Renaudin, H ^a   Charron, A ^a   Bebear C ^a   Bebear C M ^a  

^a Univ Victor Segalen Bordeaux 2   (France)

Author keywords

Macrolides; Resistance mechanism; Ribosomal mutation; Ureaplasma parvum

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; JOSAMYCIN; KETOLIDE; MACROLIDE; PRISTINAMYCIN; PROTEIN L22; PROTEIN L4; QUINUPRISTIN; RIBOSOME PROTEIN; RIBOSOME RNA; STREPTOGRAMIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ASSOCIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA GENE; SEQUENCE ANALYSIS; UREAPLASMA; UREAPLASMA PARVUM;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; OPERON; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; UREAPLASMA;

EID: 33846116734     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.09.008     Document Type: Article

References (15)

1. Waites K., and Talkington D. New developments in human diseases due to mycoplasmas. In: Blanchard A., and Browning G.F. (Eds). Mycoplasmas: molecular biology, pathogenicity and strategies for control (2005), Horizon Bioscience, Norfolk
2. Robertson J.A., Stemke G.W., Davis Jr. J.W., et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol 52 (2002) 587-597
3. Bébéar C.M., and Kempf I. Antimicrobial therapy and antimicrobial resistance. In: Blanchard A., and Browning G.F. (Eds). Mycoplasmas: molecular biology, pathogenicity and strategies for control (2005), Horizon Bioscience, Norfolk
4. Pereyre S., Renaudin H., Charron A., Bébéar C., and Bébéar C.M. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J Antimicrob Chemother 57 (2006) 753-756
5. Pereyre S., Guyot C., Renaudin H., Charron A., Bébéar C., and Bébéar C.M. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother 48 (2004) 460-465
6. Pereyre S., Gonzalez P., de Barbeyrac B., et al. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob Agents Chemother 46 (2002) 3142-3150
7. Matsuoka M., Narita M., Okazaki N., et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 48 (2004) 4624-4630
8. Lucier T.S., Heitzman K., Liu S.K., and Hu P.C. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother 39 (1995) 2770-2773
9. Furneri P.M., Rappazzo G., Musumarra M.P., Dipietro P., Catania L.S., and Roccasalva L.S. Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis. Antimicrob Agents Chemother 45 (2001) 2958-2960
10. Waites KB, Bébéar CM, Roberston JA, Talkington DF, Kenny GE, editors. Cumitech 34: Laboratory diagnosis of mycoplasmal infections. Washington DC: American Society for Microbiology; 2001.
11. Carret G., Cavallo J.-D., Chardon H., et al. Comité de l'Antibiogramme de la Société Française de Microbiologie. Report 2003. Int J Antimicrob Agents 21 (2003) 364-391
12. Palu G., Valisena S., Barile M.F., and Meloni G.A. Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains. Eur J Epidemiol 5 (1989) 146-153
13. Vester B., and Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45 (2001) 1-12
14. Leclercq R., and Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 46 (2002) 2727-2734
15. Wang G., and Taylor D.E. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 42 (1998) 1952-1958